MC-Val-Cit-PAB-Amide-TLR7 agonist 4

[2413016-49-4]

12352005

EGFR; Toll-like Receptor (TLR)

Reference compound

Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

COVID-19-immunoregulation

Inflammation/Immunology

https://www.medchemexpress.com/mc-val-cit-pab-amide-tlr7-agonist-4.html

99.39

10 mM in DMSO

O=C(C=CC1=O)N1CCCCCC(N[C@H](C(N[C@H](C(NC2=CC=C(COC(NC(C)(C)C(NCCOC(C)(C)CN3C(C4=CC=CC=C4N=C5N)=C5N=C3COCC)=O)=O)C=C2)=O)CCCNC(N)=O)=O)C(C)C)=O

C52H72N12O11

1041.20

[1]Valerie Odegard, et al. Compositions for the treatment of disease with immune stimulatory conjugates. WO2020056008 A1.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

Reference compound1

No Development Reported

ErbB2/HER2; TLR7; TLR8